Related by context. Frequent words. (Click for all words.) 68 Pivotal Phase III 67 Nexavar ® 65 BAY #-# 65 R sorafenib tablets 65 Pirfenidone 65 dalbavancin 64 Irinotecan 64 Phase III Clinical Trial 64 FDA Accepts 64 Panzem R 64 DAVANAT 63 alvimopan 63 Amrubicin 63 Lenalidomide 63 Patient Enrollment 63 Phase III Trial 63 Presents Positive 63 Drug Candidate 63 Benign Prostatic Hyperplasia 62 Voreloxin 62 liposomal formulation 62 Pivotal Phase 62 mTOR inhibitor 62 Onalta 62 Vandetanib 62 pseudobulbar affect PBA 62 AVAX 62 Generic Version 62 phase IIb clinical 62 Bortezomib 62 Rebif ® 61 Gemcitabine 61 Bevacizumab 61 Clinical Trial Results 61 eniluracil 61 6R BH4 61 Alemtuzumab 61 Epratuzumab 61 Icatibant 61 KNS # 61 BEMA TM Fentanyl 61 Clevudine 61 Monotherapy 61 Bicifadine 61 Carfilzomib 61 CoFactor 61 Telavancin 61 Barrier Therapeutics Inc. 61 luteinizing hormone releasing 61 Hycamtin 61 Pharmion Corporation 60 Rivaroxaban 60 Treanda 60 oral anticoagulant 60 ADVEXIN 60 anticancer compound 60 KRN# 60 OPAXIO 60 SinuNase 60 Phenoptin 60 EOquin 60 Mipomersen 60 Extended Release 60 Laquinimod 60 Satraplatin 60 metastatic hormone refractory 60 Erlotinib 60 Palatin Technologies 59 EFAPROXYN 59 silodosin 59 Phase IIb trials 59 Eltrombopag 59 pertuzumab 59 temsirolimus 59 ATL# [001] 59 TYKERB 59 Well Tolerated 59 ANYARA 59 BioDelivery Sciences 59 R bortezomib 59 Arixtra 59 EndoTAG TM -1 59 ImmunoCellular Therapeutics 59 PhosLo 59 TELCYTA 59 bevacizumab Avastin 59 Anika Therapeutics 59 Dasatinib 59 Trastuzumab 59 Everolimus 58 Advanced Magnetics 58 Desmoteplase 58 Oracea 58 TOCOSOL Paclitaxel 58 Sunesis Pharmaceuticals 58 Vilazodone 58 Allovectin 7 R 58 MEK inhibitor 58 Virulizin R 58 Anturol 58 VIA Pharmaceuticals